June 14, 2024
8,419
434
86
6.18%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
11:51Now PlayingSupport our work
The Supreme Court has unanimously rejected a challenge from anti-abortion groups to the nationwide availability of the abortion medication mifepristone, which is available by mail and can be taken at home in many states. However, advocates warn the far-right-dominated court's ruling on the FDA's authority to regulate the pill was purely on procedural grounds, and could even offer a "roadmap" for future challenges. Mifepristone is used in roughly two-thirds of all U.S. abortions, including in some states that have severely limited or banned abortions. "This is just one of the strikes — not the first strike, not the second or third, but one of the strikes — in an artillery that is aimed at reproductive freedom," says our guest, legal scholar Michele Goodwin. We discuss the ruling and the anti-abortion movement's "playbook" of attacks on reproductive healthcare with Goodwin.
Democracy Now! is an independent global news hour that airs on over 1,500 TV and radio stations Monday through Friday. Watch our livestream at democracynow.org Mondays to Fridays 8-9 a.m. ET.
Subscribe to our Daily Email Digest
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.